Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Both medications have shown impressive results in managing blood sugar and promoting weight loss, but they have unique characteristics that set them apart
Most people see no scale movement in the first month while on the 3 mg starter dose
They act on the brain to tell us we are full and to decrease appetite Both drugs are injectable peptides that mimic a natural hormone, glucagon-like peptide-1 (GLP-1)
Larger reductions usually happen after dose increases
Szilrd Kiss, an ophthalmologist at Weill Cornell Medicine in New York, was watching for the same pattern in patients taking tirzepatide, sold as Mounjaro and Zepbound
GLP-1 therapy can be transformative for many individuals seeking effective, medically supported weight loss
US$ 27.59
US$ 26.71
US$ 25.54
US$ 24.99
US$ 23.49
